New research from the University of Virginia shows people who have serious cases of COVID or influenza face another risk ...

The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school. But for many, the virus leaves behind a lasting impact—especially in ...

Add Yahoo as a preferred source to see more of our stories on Google. A 3D illustration of human lungs. The Food and Drug Administration on Tuesday approved a new drug for idiopathic pulmonary ...

Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...

Study found which abnormal cells talk to each other in harmful ways and perpetuate lung damage Scientists are already exploring therapeutic strategies based on this study’s discoveries Treatments also ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections.